financetom
Business
financetom
/
Business
/
Merck boosts cancer portfolio with $6.7 billion buyout of Terns Pharma
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Merck boosts cancer portfolio with $6.7 billion buyout of Terns Pharma
Mar 25, 2026 4:05 AM

March 25 (Reuters) - Merck ( MRK ) said on Wednesday it

would buy biotech Terns Pharma in a deal valued at up

to $6.7 billion, as the drugmaker races to bolster its cancer

pipeline ahead of the looming patent loss for its blockbuster

therapy Keytruda.

(Reporting by Siddhi Mahatole in Bengaluru; Editing by Sriraj

Kalluvila)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved